Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Ginsenoside F1 medicinal uses

A technology of ginsenosides and drugs, applied in the field of medicine, can solve the problems of high fatality rate, low cure rate, difficult treatment, etc., and achieve the effect of small side effects

Inactive Publication Date: 2006-10-04
海口绿科南药研究开发有限公司
View PDF0 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Although aplastic anemia is a rare disease, the social impact caused by its dangerous manifestations, serious complications and high mortality far exceeds its incidence
Since the 1970s, the treatment methods for aplastic anemia have been continuously improved, such as bone marrow transplantation, blood transfusion, immunosuppression, androgen, and hematopoietic cytokines. The prognosis of aplastic anemia has been significantly improved, but the cure rate is still low. The fatality rate is still high, so the treatment of this disease is still a worldwide problem

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Ginsenoside F1 medicinal uses

Examples

Experimental program
Comparison scheme
Effect test

preparation example 1

[0047] Preparation Example 1 Ginsenoside F 1 preparation of

[0048] 500mg ginsenoside Re and 150mg naringinase were dissolved in 50ml of phosphoric acid-citric acid buffer (pH 4.5, ionic strength 0.01M, containing 10% ethanol), hydrolyzed in a water bath at 40°C for 7 days; the reaction solution was centrifuged Collect the precipitate; wash the precipitate with 10ml of water, wash 3 times (10ml×3), combine the washing liquid with the mother liquor, concentrate to 50ml for reuse; wash the precipitate with 10ml ethanol, wash 5 times (10ml×5), combine the ethanol solution, Evaporate to dryness and collect the residue to obtain ginsenoside F 1 301 mg. Determination of Ginsenoside F by HPLC 1 The content is 63%.

preparation example 2

[0049] Preparation Example 2 Ginsenoside F 1 preparation of

[0050] 500mg Ginsenoside Rg 1 , 150mg of naringinase was dissolved in 50ml of glycine-HCl buffer (pH 4.5, ionic strength 0.01M, containing 10% dimethyl sulfoxide), and hydrolyzed in a water bath at 40°C for 7 days; the reaction solution was centrifuged to collect the precipitate ; Wash the precipitate with 10ml of water, wash 3 times (10ml × 3), combine the lotion with the mother liquor, concentrate to 50ml for reuse; wash the precipitate with 10ml of ethanol, wash 5 times (10ml × 5), combine the ethanol solution, evaporate to dryness , collect the residue to get ginsenoside F 1 325mg. Determination of Ginsenoside F by HPLC 1 The content is 84%.

preparation example 3

[0051] Preparation Example 3 Ginsenoside F 1 preparation of

[0052] 500mg Ginsenosides Re and Rg 1 The mixture, 150mg of naringinase was dissolved in 50ml of acetic acid-sodium acetate buffer solution (pH 4.5, ionic strength of 0.01M, containing 10% formamide), and hydrolyzed in a water bath at 40°C for 7 days; the reaction solution was collected by centrifugation Precipitate; wash the precipitate with 10ml of water, wash 3 times (10ml×3), combine the lotion with the mother liquor, concentrate to 50ml for reuse; wash the precipitate with 10ml ethanol, wash 5 times (10ml×5), combine the ethanol solution, distill Dry and collect the residue to get ginsenoside F 1 310mg. Determination of Ginsenoside F by HPLC 1 The content is 69%.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

Disclosed is the use of Ginsenoside F1 in preparing medicament for the treatment of regenerative anemia.

Description

technical field [0001] The present invention relates to the technical field of medicine, specifically ginsenoside F 1 (ginsenoside F 1 ) for medicinal purposes. [0002] [0003] Ginsenoside F 1 [0004] Molecular formula: C 36 h 62 o 9 Molecular weight: 638.87 Background technique [0005] Ginseng (Panax ginseng C.A.Mey.) is the root of the Araliaceae plant ginseng, which is distributed in the deep mountains of Heilongjiang, Jilin, Liaoning and northern Hebei. As a commonly used Chinese herbal medicine, it was first recorded in "Shen Nong's Materia Medica" in the Han Dynasty, and was listed as top grade. Ginseng is warm in nature, sweet and slightly bitter in taste, and has the functions of invigorating vital energy, solidifying and promoting body fluid, improving intelligence and calming the nerves. It is used to treat exhaustion due to fatigue, lack of food, fatigue, nausea and vomiting, slippery stool, cough due to deficiency, shortness of breath, spontaneous...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K31/704A61P7/06
Inventor 吴巍滕厚雷
Owner 海口绿科南药研究开发有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com